Skip to main content
ImmuneCited
Figure 3

More Figures from This Paper

Figure 1

Figure 1
Figure 2

Figure 2
Figure 4

Figure 4

Figure 3

995 × 338px · 199.9 KB

Source Paper

Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovascular Drugs and Future Directions.

Biomedicines (2025)

PMID: 40426881

DOI: 10.3390/biomedicines13051053

Cite This Figure

![Figure 3: Figure 3](https://pdfs.citedhealth.com/figures/40426881/225.png)

> Source: Toshiki Otoda et al. "Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovasc." *Biomedicines*, 2025. PMID: [40426881](https://pubmed.ncbi.nlm.nih.gov/40426881/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/40426881/225.png" alt="Figure 3" />
  <figcaption>Figure 3. Figure 3<br>  Source: Toshiki Otoda et al. "Lysosomal Stress in Cardiovascular Diseases: Therapeutic Potential of Cardiovasc." <em>Biomedicines</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40426881/">40426881</a></figcaption>
</figure>

Related Evidence

A
Curcumin for Chronic Inflammation

Grade A · 10 studies

 C
Resveratrol for Chronic Inflammation

Grade C · 5 studies